Viking Therapeutics (NASDAQ:VKTX) Research Coverage Started at Scotiabank
Scotiabank assumed coverage on shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) in a report issued on Thursday morning, Marketbeat.com reports. The brokerage issued a sector outperform rating and a $102.00 target price on the biotechnology company’s stock. A number of other research analysts also recently weighed in on the company. Maxim Group lowered their […]
Scotiabank assumed coverage on shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) in a report issued on Thursday morning, Marketbeat.com reports. The brokerage issued a sector outperform rating and a $102.00 target price on the biotechnology company’s stock. A number of other research analysts also recently weighed in on the company. Maxim Group lowered their […]
